Hochuen Medical, a Shenzhen, China-based medical technology company, raised RMB 40M in Series A funding.
The round was led by Qiming Venture Partners.
The company intends to use the funds to accelerate its contract development and manufacturing organization, expand in both international and domestic markets, develop new manufacturing processes and technologies, and further expand production capacity.
Founded in 2015 by Dr. Robin Liu, an entrepreneur in IVD medical and microfluidics fields, and Eric Zeng, an expert in the electronics OEM industry, Hochuen Medical is developing and producing microfluidic and IVD devices for more than 200 companies, including the world’s largest IVD companies, and DNA microarrays and gene sequencing companies. The products include microfluidic cartridges, in vitro diagnostic (IVD) disposables, Point of Care Test (POCT) devices, life science research disposables, gene sequencing chips, animal and plant disease testing cartridges, food safety screening devices, etc.
The company, which can support customers from the R&D phase to low and high volume CDMO manufacturing services on microfluidic chips and biomedical consumables, has four manufacturing sites in China and Malaysia, with tens of thousands of square meters of manufacturing facilities (including clean rooms and GMP rooms), and sales offices in the United States and Singapore.